pharma news

News

ACIP votes down recommendation allowing MSD's MMRV shot as an option for children under four, but there's confusion about the coverage implications.

News

There is only one approved drug for ultra-rare disease FOP on the market, but Regeneron is hoping to add a second.

News

Novo Nordisk has trumpeted data showing oral Wegovy matched the injectable version in a phase 3 trial, ramping up pressure on rival Eli Lilly.

News

Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its phase 3 candidate pegozafermin for MASH.

News

Fired CDC chief Susan Monarez told the Senate HELP committee today that HHS Secretary Kennedy has a plan to change to child vaccinations this month.

News

Eli Lilly is preparing to file for approval of its oral weight-loss drug orforglipron before year-end, but not all are convinced by the data.